In conclusion, concomitant use of nsNSAIDs, COX-2 inhibitors, or low-dose aspirin with SSRIs is associated with a significantly increased risk of diagnosed UGIB
In conclusion, concomitant use of nsNSAIDs, COX-2 inhibitors, or low-dose aspirin with SSRIs is associated with a significantly increased risk of diagnosed UGIB